Abnormal atrial activation in young patients with lone atrial fibrillation

Europace

Volumn 13, Issue 2, 2011, Pages 188-192

  Holmqvist, Fredrik ^a   Olesen, Morten S ^b   Tveit, Arnljot ^c   Enger, Steve ^c   Tapanainen, Jari ^d   Jurkko, Raija ^d   Havmöller, Rasmus ^a   Haunsø, Stig ^b,e   Carlson, Jonas ^a   Svendsen, Jesper H ^b,e   Platonov, Pyotr G ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c VESTRE VIKEN HOSPITAL TRUST   (Norway)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Atrial fibrillation; Early onset; P wave morphology; Signal averaged ECG

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; MALE; P WAVE; PRIORITY JOURNAL; Q WAVE;

ADULT; ATRIAL FIBRILLATION; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE;

EID: 79251505301     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq352     Document Type: Article

References (30)

1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Com-mittee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collabor-ation with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-354.
2. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2-9N.
3. Smith JG, Platonov P, Hedblad B, Engström G, Melander O. Atrial fibrillation in the Malmö diet and cancer study: a study of occurence, riskfactors and diagnostic validity. Eur J Epidemiol 2010;25:95-102.
4. Stewart S, MacIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scot-land, 1986-1996. Eur Heart J 2001;22:693-701.
5. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary pre-vention. Circulation 2003;108:711-6.
6. Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997;95:572-6.
7. Allessie MA, Lammers WJEP, Bonke FIM, Hollen JM. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Zipes DP, Jalife J (eds). Cardiac Electrophysiology and Arrhythmias. Orlando, FL: Grune & Stratton; 1985. p265-75.
8. Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable microreentrant sources as a mechanism ofatrialfibrillation in the isolated sheep heart. Circulation 2000;101:194-9.
9. Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia indepen-dent of focal discharge. Am Heart J 1959;58:59-70.
10. Skanes AC, Mandapati R, Berenfeld O, Davidenko JM, Jalife J. Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart. Circulation 1998; 98:1236-48.
11. Fukunami M, Yamada T, Ohmori M, Kumagai K, Umemoto K, Sakai A et al. Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram. Circulation 1991; 83:162-9.
12. Yamada T, Fukunami M, Ohmori M, Kumagai K, Sakai A, Kondoh N et al. Charac-teristics of frequency content of atrial signal-averaged electrocardiograms during sinus rhythm in patients with paroxysmal atrial fibrillation.J Am Coll Cardiol 1992; 19:559-63.
13. Budeus M, Hennersdorf M, Perings C, Wieneke H, Erbel R, Sack S. Prediction of the recurrence of atrial fibrillation after successful cardioversion with P wave signal-averaged ECG. Ann Noninvasive Electrocardiol 2005;10:414-9.
14. Jurkko R, Vaananen H, Mantynen V, Kuusisto J, Makijarvi M, Toivonen L High-resolution signal-averaged analysis of atrial electromagnetic characteristics in patients with paroxysmal lone atrial fibrillation. Ann Noninvasive Electrocardiol 2008;13:378-85.
15. Platonov PG, Carlson J, Ingemansson MP, Roijer A, Hansson A, Chireikin LV et al. Detection of inter-atrial conduction defects with unfiltered signal-averaged P-wave ECG in patients with lone atrial fibrillation. Europace 2000;2:32-41.
16. Holmqvist F, Husser D, Tapanainen JM, Carlson J, Jurkko R, Xia Y et al. Interatrial conduction can be accurately determined using standard 12-lead electrocardio-graphy: Validation of P-wave morphology using electroanatomic mapping in man. Heart Rhythm 2008;5:413-8.
17. Holmqvist F, Platonov PG, Carlson J, Zareba W, Moss AJ. Altered interatrial con-duction detected in MADIT II patients bound to develop atrial fibrillation. Ann Noninvasive Electrocardiol 2009;14:268-75.
18. Havmoller R, Carlson J, Holmqvist F, Herreros A, Meurling CJ, Olsson B et al. Age-related changes in P wave morphology in healthy subjects. BMC Cardiovasc Disord 2007;7:22.
19. Holmqvist F, Platonov PG, McNitt S, Polonsky S, Carlson J, Zareba W et al. Abnormal P-wave morphology is a predictor of atrial fibrillation development and cardiac death in MADIT II patients. Ann Noninvasive Electrocardiol 2010;15: 63-72.
20. Holmqvist F, Havmoller R, Platonov P, Carlson J. Signal-averaged P wave analysis for delineation of interatrial conduction-Further validation of the method. BMC Cardiovasc Disord 2007;7:29.
21. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
22. Hanna IR, Heeke B, Bush H, Brosius L, King-Hageman D, Beshai JF et al. The relationship between stature and the prevalence of atrial fibrillation in patients with left ventricular dysfunction.JAm Coll Cardiol 2006;47:1683-8.
23. Rosengren A, Hauptman PJ, Lappas G, Olsson L, Wilhelmsen L, Swedberg K Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J 2009;30:1113-20.
24. Perez MV, Dewey FE, Marcus R, Ashley EA, Al-Ahmad AA, Wang PJ et al. Electro-cardiographic predictors of atrial fibrillation. Am Heart J 2009;158:622-8.
25. Cui G, Tung T, Kobashigawa J, Laks H, Sen L Increased incidence of atrial flutter associated with the rejection of heart transplantation. Am J Cardiol 2001;88: 280-4.
26. Holmqvist F, Platonov PG, Carlson J, Havmoller R, Waktare JE, McKenna WJ et al. Variable interatrial conduction illustrated in a hypertrophic cardiomyopathy population. Ann Noninvasive Electrocardiol 2007;12:227-36.
27. Havmoller R, Carlson J, Holmqvist F, Olsson B, Platonov P. Evolution of P-wave morphology in healthy individuals: a 3-year follow-up study. Ann Noninvasive Elec-trocardiol 2009;14:226-33.
28. Bayes de Luna A, Cladellas M, Oter R, Torner P, Guindo J, Marti V et al. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia. Eur Heart J 1988;9:1112-8.
29. Chaldoupi SM, Loh P, Hauer RN, de Bakker JM, van Rijen HV The role of con-nexin40 in atrial fibrillation. Cardiovasc Res 2009;84:15-23.
30. Burstein B, Comtois P, Michael G, Nishida K, Villeneuve L, Yeh YH et al. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure. Circ Res 2009;105:1213-22.